Empaken 10

Empaken 10, Empagliflozin 10mg

Description

Empaken Empagliflozin 10mg/ 25mg
Empaken is an SGLT2 inhibitor
Empaken reduces reabsorption of filtered glucose
from the tubular lumen and lowers the renal

threshold for glucose (RTG).

Empaken is preferred as an additional antidiabetic
agent or alternative first
line agent in patients
Empaken has proven cardiovascular and renal
benefits

Therapeutic Use T2DM treatment either as;
First line
Add on
Heart Failure
add on for CV protection
Proven benefits

Reduced MI, stroke, CHF hospitalization and
cardiovascular death

Reduced risk of kidney disease, reduced worsening
of kidney disease

Additional information

Dosage Form

Tablets

Pack Size

14

Strength

10 mg